Published in Annu Rev Biochem on January 01, 1980
The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J (1987) 4.00
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58
Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors. Proc Natl Acad Sci U S A (1984) 2.34
Molecular intercommunication between the complement and coagulation systems. J Immunol (2010) 2.12
Characterization of an almost full-length cDNA coding for human blood coagulation factor X. Proc Natl Acad Sci U S A (1985) 2.08
Multiple zones in the sequence of calreticulin (CRP55, calregulin, HACBP), a major calcium binding ER/SR protein. EMBO J (1989) 1.91
High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A (1981) 1.83
The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci U S A (1985) 1.79
Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A (1987) 1.75
Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J (1990) 1.65
A revisit to the one form kinetic model of prothrombinase. Biophys Chem (2010) 1.63
Identification of polypeptides encoded by an Escherichia coli locus (hflA) that governs the lysis-lysogeny decision of bacteriophage lambda. J Bacteriol (1987) 1.62
Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145. Proc Natl Acad Sci U S A (1983) 1.57
The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J (1988) 1.54
Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med (1982) 1.53
Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J (1983) 1.51
Site-specific interaction of thrombin and inhibitors observed by fluorescence correlation spectroscopy. Biophys J (1997) 1.50
Interactions between coagulation and complement--their role in inflammation. Semin Immunopathol (2011) 1.46
Problems with anticoagulants. Br Med J (Clin Res Ed) (1982) 1.37
Translational diffusion of bovine prothrombin fragment 1 weakly bound to supported planar membranes: measurement by total internal reflection with fluorescence pattern photobleaching recovery. Biophys J (1994) 1.34
Chemotactic response of monocytes to thrombin. J Cell Biol (1983) 1.33
Sampling the N-terminal proteome of human blood. Proc Natl Acad Sci U S A (2010) 1.28
Development-specific protein S of Myxococcus xanthus: purification and characterization. J Bacteriol (1981) 1.27
Primary structure of bovine vitamin K-dependent protein S. Proc Natl Acad Sci U S A (1986) 1.26
Blood coagulation factor X mRNA encodes a single polypeptide chain containing a prepro leader sequence. Nucleic Acids Res (1984) 1.20
The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition. Blood (2010) 1.18
Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc Natl Acad Sci U S A (1989) 1.17
Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J (1986) 1.17
Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A (1990) 1.15
Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci U S A (1986) 1.13
Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci U S A (1986) 1.12
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
Na+ binding to meizothrombin desF1. Cell Mol Life Sci (2008) 1.10
Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J (1994) 1.10
Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest (1985) 1.08
The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments. Biochem J (1982) 1.07
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. J Biol Chem (2005) 1.07
Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1. J Biol Chem (2010) 1.07
A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism. EMBO J (1988) 1.06
Gene deletion in an Italian haemophilia B subject. J Med Genet (1985) 1.05
Primary structures of bovine liver low molecular weight kininogen precursors and their two mRNAs. Proc Natl Acad Sci U S A (1983) 1.02
Human monocytes have prothrombin cleaving activity. Clin Exp Immunol (1983) 1.00
Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase. J Biol Chem (2007) 1.00
Human coagulation factor Va is a cofactor for the activation of protein C. Proc Natl Acad Sci U S A (1983) 0.99
Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants. EMBO J (1997) 0.99
FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa. Biochem J (2007) 0.97
Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci U S A (1986) 0.97
Binding of human blood-coagulation Factors IXa and X to phospholipid membranes. Biochem J (1984) 0.96
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J Clin Invest (1984) 0.96
Identification of a single nucleotide C-to-T transition and five different deletions in patients with severe hemophilia B. Am J Hum Genet (1989) 0.95
Fibrinogen and fibrin structure and fibrin formation measured by using magnetic orientation. Proc Natl Acad Sci U S A (1983) 0.94
Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization. Biophys J (2003) 0.94
The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. Biochem J (1986) 0.94
Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line. J Clin Invest (1984) 0.94
Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin. Biochem J (1983) 0.94
Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species. Proc Natl Acad Sci U S A (1992) 0.93
Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence. Nucleic Acids Res (1987) 0.93
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. Protein Sci (1993) 0.93
Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase. J Biol Chem (2008) 0.92
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem J (2003) 0.91
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry (2007) 0.90
The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Biochem J (1984) 0.89
Influence of solvent and intramolecular hydrogen bonding on the conformational properties of o-linked glycopeptides. J Phys Chem B (2011) 0.89
Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. J Clin Invest (1984) 0.89
Factor XA binding to phosphatidylserine-containing membranes produces an inactive membrane-bound dimer. Biophys J (2009) 0.89
Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J (1982) 0.89
Comparative study of anticoagulant and procoagulant properties of 28 snake venoms from families Elapidae, Viperidae, and purified Russell's viper venom-factor X activator (RVV-X). Toxicon (2010) 0.87
Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors. J Clin Invest (1983) 0.86
Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. J Clin Invest (1984) 0.86
Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin. J Cell Biochem (2012) 0.86
Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase. Thromb Haemost (2012) 0.85
Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J (1990) 0.85
Functional and structural characterization of factor Xa dimer in solution. Biophys J (2009) 0.85
Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry (2009) 0.85
Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution. Biochemistry (2012) 0.85
Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site. Biophys J (1996) 0.84
Intrinsic versus extrinsic coagulation. Kinetic considerations. Biochem J (1986) 0.84
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site. J Clin Invest (1985) 0.82
Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site. Proc Natl Acad Sci U S A (1987) 0.82
X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa. EMBO J (1997) 0.82
Folding autonomy of the kringle 4 fragment of human plasminogen. Proc Natl Acad Sci U S A (1983) 0.81
Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells. Biochemistry (2012) 0.81
A novel serine protease predominately expressed in macrophages. Biochem J (2003) 0.81
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C. Thromb Haemost (2009) 0.80
Effect of metal ion substitutions in anticoagulation factor I from the venom of Agkistrodon acutus on the binding of activated coagulation factor X and on structural stability. J Biol Inorg Chem (2009) 0.80
Induction of prothrombin synthesis by prothrombin fragments. Proc Natl Acad Sci U S A (1981) 0.80
Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence. Biochem J (1987) 0.80
Deriving the generic structure of the fibronectin type II domain from the prothrombin Kringle 1 crystal structure. EMBO J (1987) 0.80
Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion. J Clin Invest (1991) 0.80
Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin. J Clin Invest (1986) 0.80
The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4. Nucleic Acids Res (1987) 0.80
Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation. Biochem J (1995) 0.77
Large-scale molecular dynamics simulation: Effect of polarization on thrombin-ligand binding energy. Sci Rep (2016) 0.77
Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion. Inflammation (2015) 0.77
Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex. Biochemistry (2008) 0.77
Coagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearance. PLoS One (2012) 0.75
Inflammatory Function of CX3CR1+ CD8+ T Cells in Treated HIV Infection Is Modulated by Platelet Interactions. J Infect Dis (2016) 0.75
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature (1996) 3.40
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Properties of the factor Xa binding site on human platelets. J Biol Chem (1978) 2.59
Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. J Biol Chem (1977) 2.21
The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem (1974) 2.19
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science (1972) 2.07
Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sci U S A (1977) 2.03
Purification and characterization of bovine tissue factor. J Biol Chem (1981) 1.99
Tissue factor revisited. Prog Hemost Thromb (1982) 1.86
Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am J Respir Cell Mol Biol (1998) 1.86
DYSTROPHIC MORPHOLOGY AND ITS SIGNIFICANCE. Science (1923) 1.82
Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol (1981) 1.82
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry (1986) 1.68
A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proc Natl Acad Sci U S A (1973) 1.65
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost (2003) 1.64
Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate. Br J Clin Pharmacol (1999) 1.63
Prothrombin structure, activation, and biosynthesis. Physiol Rev (1977) 1.61
Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood (1992) 1.61
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood (2000) 1.59
Release of active tissue factor by human arterial smooth muscle cells. Circ Res (2000) 1.57
Association of tissue factor activity with the surface of cultured cells. J Clin Invest (1975) 1.52
ON THE IMPROVEMENT OF MEDICAL TEACHING. Science (1912) 1.43
Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem (1980) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Studies on bovine factor X. II. Characterization of purified factor X. Observations on some alterations in zone electrophoretic and chromatographic behavior occurring during purification. Biochemistry (1968) 1.31
The reaction between bovine brain tissue factor and factors VII and X. Biochemistry (1966) 1.30
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem (1997) 1.29
Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem (1980) 1.28
In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest (1996) 1.26
Solution composition dependent variation in extinction coefficients for p-nitroaniline. Biochim Biophys Acta (1983) 1.25
Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem (1975) 1.24
Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry (1988) 1.22
Activation of bovine factor VII by hageman factor fragments. Blood (1977) 1.20
Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry (1992) 1.20
The tissue factor pathway of blood coagulation. Prog Hemost Thromb (1972) 1.19
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Identification of active tissue factor in human coronary atheroma. Circulation (1996) 1.18
Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost (1997) 1.18
Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc Natl Acad Sci U S A (1989) 1.17
The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin. J Biol Chem (1982) 1.16
An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. Biochemistry (1986) 1.16
Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab (1993) 1.13
Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest (1993) 1.12
An assay for coagulation factor VII using factor VII-depleted bovine plasma. J Lab Clin Med (1974) 1.12
A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol (1994) 1.11
The conversion of prothrombin to thrombin. II. Differentiation between thrombin- and factor Xa-catalyzed proteolyses. J Biol Chem (1974) 1.10
Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf (2000) 1.10
On the molecular-weight-dependence of the anticoagulant activity of heparin. Biochem J (1979) 1.09
Characterization of two glycoprotein variants of bovine factor X and demonstration that the factor X zymogen contains two polypeptide chains. Biochemistry (1972) 1.08
The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim Biophys Acta (1983) 1.08
Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J Biol Chem (1976) 1.08
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation (1996) 1.08
The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. J Biol Chem (1975) 1.07
Studies on bovine factor X. I. Large-sclae purification of the bovine plasma protein possessing factor X activity. Biochemistry (1968) 1.07
Measurement of phospholipid monolayer surface potentials at a hydrocarbon-electrolyte interface. Biochim Biophys Acta (1979) 1.06
Flow as a regulator of the activation of factor X by tissue factor. Blood (1988) 1.05
Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol (1999) 1.04
The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen. J Biol Chem (1982) 1.03
The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. J Biol Chem (1974) 1.03
Use of an oriented transmembrane protein to probe the assembly of a supported phospholipid bilayer. Biophys J (1994) 1.02
Phospholipid monolayers at the hydrocarbon-electrolyte interface. The interrelation of film potential and film pressure. Biochim Biophys Acta (1979) 1.01
Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles. Proc Natl Acad Sci U S A (1986) 1.01
The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X. J Biol Chem (1974) 1.00
Purification and characterization of tissue factor apoprotein. Methods Enzymol (1976) 1.00
Binding of the products of prothrombin activation to human platelets. J Clin Invest (1975) 1.00
Comparison of methods for detecting specific IgM antibody in infants with congenital rubella. J Med Microbiol (1978) 0.99
Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIII. Blood (1978) 0.99
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta (1994) 0.99
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Purification and characterization of the protein component of tissue factor. Biochemistry (1970) 0.98
Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry (1993) 0.98
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A (1990) 0.98
Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci U S A (1986) 0.97
Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost (2006) 0.97
Circulating tissue factor and thrombosis. Curr Opin Hematol (2000) 0.97
A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions. J Biol Chem (1974) 0.97
Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression. Blood (1994) 0.96
Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med (2000) 0.96
The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost (2001) 0.96
Gonadotrophin response after castration and selective destruction of the testicular interstitium in the normal and aspermatogenic rat. Acta Endocrinol (Copenh) (1978) 0.96
Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X. J Biol Chem (1974) 0.96
Activation of factor IX by activated factor X: a link between the extrinsic and intrinsic coagulation systems. FEBS Lett (1975) 0.96
The activation of bovine coagulation factor X. Methods Enzymol (1976) 0.94
Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol (1991) 0.94
Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis (1998) 0.94
The conversion of prothrombin to thrombin. V. The activation of prothrombin by factor Xa in the presence of phospholipid. J Biol Chem (1974) 0.94
Zymogens and cofactors of blood coagulation. CRC Crit Rev Biochem (1980) 0.93
Relationship between factor V and activated factor X in the generation of prothrombinase. Nature (1967) 0.92
Consequences of the non-specific binding of a protein to a linear polymer: reconciliation of stoichiometric and equilibrium titration data for the thrombin-heparin interaction. J Theor Biol (2000) 0.92
The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins. Thromb Res (1982) 0.92
Intimal tissue factor activity is released from the arterial wall after injury. Thromb Haemost (2000) 0.92
Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab (1993) 0.92
The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions. Blood (1993) 0.92
The action of thrombin on blood clotting factor V: conversion of factor V to a prothrombin-binding protein. Biochim Biophys Acta (1973) 0.92
The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells. Am J Respir Cell Mol Biol (1998) 0.91